(Q34139509)

31 July 2017

A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains (English)

1 reference

31 July 2017

0 references

4

Li Huei Tsai

1 reference

31 July 2017

Huang Chun Tseng

1

1 reference

31 July 2017

Ying Zhou

series ordinal

2

1 reference

31 July 2017

Yong Shen

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

31 July 2017

1 reference

31 July 2017

523

1 reference

31 July 2017

58-62

1 reference

31 July 2017

1-3

1 reference

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Proline-directed and non-proline-directed phosphorylation of PHF-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Neuronal cdc2-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Perikaryal accumulation and proteolysis of neurofilament proteins in the post-mortem rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Neurobiology: p25 protein in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902934-4

10.1016/S0014-5793(02)02934-4

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference